Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

NCT01081223 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioma
High Grade Astrocytoma
Glioblastoma Multiforme

Interventions

BIOLOGICAL: Cancer vaccine plus immune adjuvant

Sponsor

TVAX Biomedical